Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07017569 · ClinicalTrials.gov registry record · NA
An Interactive Mobile Health (mHealth) App as Intervention for High Anxiety and Depression in College Students
A NA study, sponsored by Texas A&M University.
- Completed
- Registry status
- NA
- Development phase
- 125
- Enrollment target
NCT07017569: Completed NA study, sponsored by Texas A&M University.
NCT07017569 is a NA study that has completed, run by Texas A&M University. The registered enrollment target is 125 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07017569, a NA study, has completed, sponsored by Texas A&M University.
- COMPLETED
- Registry status
- NA
- Development phase
- 125 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn if a mobile health app called mHELP can help college students manage anxiety, stress, and depression. The main questions it aims to answer are: * Does using the mHELP app reduce anxiety, stress, and depression symptoms both over time and in real-time? * Does the app help students engage with mental health services and self-management tools? Researchers will compare students who use the full version of the mHELP app to those who use a control version with limited features. Participants will: * Use an Apple Watch and iPhone app for 10 weeks * Receive reminders to complete weekly mental health questionnaires * Tap a button to report high-stress moments or respond to automatic alerts from the app * Intervention group will use app features like breathing exercises, journaling, and educational videos * Intervention group will receive 2 free telehealth counseling sessions
Primary Outcome
The primary dependent variable, "Moments of Stress" (MS), is a conceptual real-time measure derived from a combination of physiological heart rate (beats per minute - bpm) measurements and subjective self-reports, both collected through the mHELP application on the Apple Watch. Participants were prompted by the app after periods of elevated heart rate, identified using an integrated machine learning algorithm, to provide momentary self-assessments of stress using a single-item scale (e.g., "Are
Interventions
- BEHAVIORAL Mobile health application
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2021-09-20 |
| Est. Completion | 2021-12-15 |
| Phase | NA |
What the finished NCT07017569 record still lists
NCT07017569 is an interventional study that assigns participants to a tested intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 1 intervention - of which Mobile health application is the first listed.
NCT07017569 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07017569 about?
NCT07017569 is a clinical study titled "An Interactive Mobile Health (mHealth) App as Intervention for High Anxiety and Depression in College Students". The goal of this clinical trial is to learn if a mobile health app called mHELP can help college students manage anxiety, stress, and depression. The main questions it aims to answer are: * Does using the mHELP app reduce anxiety, stress, and depression symptoms both over time and in real-time? * ...
What is the current status of trial NCT07017569?
This trial is currently completed. It is a NA study. The enrollment target is 125 participants. The study started on 2021-09-20. Estimated completion is 2021-12-15.
What interventions are being tested in trial NCT07017569?
The interventions under investigation include: Mobile health application (BEHAVIORAL).
Who is sponsoring clinical trial NCT07017569?
This trial is sponsored by Texas A&M University, which has 95 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07017569's enrollment target sits among peer trials
125 753rd of 2000 higher than 1,243 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02717039 · 125 participants
Pharmacogenomics of Heparin-Induced Thrombocytopenia
- NCT02763033 · 125 participants · Phase 2
Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients
- NCT02793999 · 125 participants
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
- NCT03003299 · 125 participants · NA
PARTNER 3 Trial - Aortic Valve-in-Valve
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI